Brian Failor

Brian Failor provides support to private equity investors by evaluating the impact of healthcare coding, coverage, and reimbursement developments across all verticals.

With experience in finance and revenue cycle operations, he provides insight into regulatory and legislative activity.

Prior to joining Avalere, Brian worked at NYU Langone Health in finance and revenue cycle operations where he performed variance analyses on reimbursement and compliance concerns. Additionally, he has experience with Exela Pharma Sciences, LLC, where he conducted research to assess opportunities within supply chain operations.

Brian has a BS in health policy and administration from Penn State University.

Authored Content

Approximately ⅓ of physician services payments are eligible for telehealth reimbursement under Medicare (fee-for-service) FFS through existing Center for Medicare and Medicaid Services (CMS) guidance as of January 2020, in addition to temporary coding guidance specific to COVID-19 effective as of March 1, 2020. Avalere’s analysis highlights the immediate potential for specific physician specialties to utilize telehealth based on temporary flexibilities regarding which procedures are eligible for telehealth reimbursement.

As technology comes to the forefront in healthcare innovation, the venture capital arms of many pharmaceutical companies are solidifying their presence as key investors.